What is the recommended cumulative EQD2 (equivalent dose in 2 Gy fractions) BED (biological effective dose) for the kidney in a patient with a history of cancer undergoing radiation therapy for soft tissue sarcoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cumulative EQD2 BED for Kidney

The kidney tolerance dose is approximately 15-17 Gy in 2 Gy fractions (EQD2) for uniform external beam irradiation, with systemic radiation delivery (such as total body irradiation) having a lower threshold of approximately 12 Gy EQD2. 1

Kidney Radiation Tolerance Parameters

Standard External Beam Radiation Therapy

  • Uniform kidney irradiation tolerance: 15-17 Gy EQD2 for local external beam therapy 1
  • Systemic radiation delivery: Approximately 12 Gy EQD2 when delivered as total body irradiation in bone marrow transplant protocols 1

Radiobiological Considerations

  • The kidney demonstrates significant radiosensitivity as a dose-limiting organ 1
  • The linear-quadratic (LQ) model with an α/β ratio of 1.5-3 Gy adequately describes kidney fractionation sensitivity for doses per fraction down to approximately 1 Gy 1
  • For fraction sizes below 1 Gy, the LQ model may underestimate the biological effectiveness 1

Clinical Context for Soft Tissue Sarcoma

Standard Radiation Doses for Sarcoma Treatment

While treating soft tissue sarcoma, the kidney constraint becomes critical when:

  • Retroperitoneal/intra-abdominal sarcomas are treated with 45-50 Gy in standard fractionation 2
  • Postoperative radiation delivers 50 Gy external beam with potential boost doses of 10-26 Gy depending on margin status 2
  • Total cumulative doses can reach 60-76 Gy to the tumor bed with positive margins 3, 4

Critical Pitfall

The kidney tolerance of 15-17 Gy EQD2 is substantially lower than typical sarcoma treatment doses (50-60 Gy), making kidney sparing absolutely essential in retroperitoneal cases. 1, 2 Advanced techniques including IMRT, tomotherapy, or proton therapy should be utilized to maintain kidney doses below tolerance thresholds 2

Dose-Time Relationship

  • The time to expression of radiation nephropathy is dose-dependent 1
  • Features of radiation nephropathy appear similar across external beam therapy, total body irradiation, and radionuclide therapy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Radioterapia Adjuvante para Sarcoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Radioterapia Pós-operatória para Sarcoma de Partes Moles

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.